Resapp Health Ltd
ASX:RAP

Watchlist Manager
Resapp Health Ltd Logo
Resapp Health Ltd
ASX:RAP
Watchlist
Price: 0.205 AUD Market Closed
Market Cap: 176.2m AUD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
N/A
Revenue
Forecast
N/A
Operating Income
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

RAP Price Targets Summary
Resapp Health Ltd

There are no price targets for RAP.
RAP Lowest Forecast
Wall Street Target
Not Available
RAP Average Forecast
Wall Street Target
Not Available
RAP Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Resapp Health Ltd Competitors:
Price Targets
C
CCLD
CareCloud Inc
80% Upside
HCAT
Health Catalyst Inc
120% Upside
OMCL
Omnicell Inc
61% Upside
CRW
Craneware PLC
41% Upside
C
CCLD
CareCloud Inc
80% Upside
HCAT
Health Catalyst Inc
120% Upside
OMCL
Omnicell Inc
61% Upside
CRW
Craneware PLC
41% Upside
CERT
Certara Inc
53% Upside
NXU
Nexus AG
1% Downside
4480
Medley Inc
60% Upside
FORA
Forian Inc
137% Upside

Revenue
Forecast

Revenue Estimate
Resapp Health Ltd

The compound annual growth rate of Resapp Health Ltd's revenue for the next 2 years is 32%.

N/A
Past Growth
32%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Resapp Health Ltd

Operating Income forecast
is not available for
Resapp Health Ltd

Net Income
Forecast

Net Income Estimate
Resapp Health Ltd

Net Income forecast
is not available for
Resapp Health Ltd

See Also

Summary
RAP intrinsic value, competitors valuation, and company profile.
DCF Valuation
RAP stock valuation using Discount Cash Flow valuation method.
Relative Valuation
RAP stock valuation using valuation multiples.
Wall Street Estimates
RAP price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
RAP stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RAP's stock price target?
Not Available

RAP doesn't have any price targets made by Wall Street professionals.

What is Resapp Health Ltd's Revenue forecast?
Projected CAGR
32%

The compound annual growth rate of Resapp Health Ltd's revenue for the next 2 years is 32%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 263,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.